Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant

Clinical trial NCT03961919 · COMPLETED

Trial details

NCT number: NCT03961919
Sponsor: Ciceri Fabio
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes Transplant-Related Hematologic Malignancy

Start date: 2009-02-10
Primary completion: 2019-12-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.